::個(gè)人資料::
姓 名：何渡
性 別：男
學(xué)歷學(xué)位：博士
職 稱(chēng)：副主任醫(yī)師
職 務(wù)：腫瘤一科副主任
E-mail ： [email protected]
研究方向：腫瘤的靶向治療
單位：湖北民族大學(xué)附屬恩施州中心醫(yī)院
::個(gè)人簡(jiǎn)介：::
何渡,，男,，腫瘤一科副主任，武漢大學(xué)人民醫(yī)院腫瘤學(xué)博士研究生。先后到國(guó)內(nèi)頂級(jí)的中山大學(xué)腫瘤醫(yī)院及湖北省人民醫(yī)院進(jìn)修學(xué)習(xí),。主要方向?yàn)槊谀蛳到y(tǒng)腫瘤、消化系統(tǒng)腫瘤及婦科腫瘤,。率先在恩施州開(kāi)展了宮頸癌的插植治療及膀胱掃描儀在盆腔腫瘤中的應(yīng)用的新技術(shù),。承擔(dān)湖北省青年基金一項(xiàng)，參編醫(yī)學(xué)著作5部,，撰寫(xiě)醫(yī)學(xué)論文近20余篇,，其中SCI論文10余篇。任中國(guó)研究型醫(yī)院精準(zhǔn)醫(yī)學(xué)與腫瘤MDT專(zhuān)業(yè)委員會(huì)青年委員,，湖北省抗癌協(xié)會(huì)胃癌專(zhuān)業(yè)委員會(huì)委員,，湖北省抗癌協(xié)會(huì)婦瘤專(zhuān)業(yè)委員會(huì)委員，湖北省抗癌協(xié)會(huì)靶向治療專(zhuān)業(yè)委員會(huì)委員,。
::目前承擔(dān)的研究項(xiàng)目及經(jīng)費(fèi)：::
基于人工智能及組學(xué)技術(shù)建立多模態(tài)肝細(xì)胞癌的分子診斷及預(yù)后模型,，湖北省衛(wèi)生健康委科研項(xiàng)目（青年人才項(xiàng)目），2021/01-2022/12，8萬(wàn)(縱向經(jīng)費(fèi)),，項(xiàng)目主持人,；
::科研成果及獎(jiǎng)勵(lì)：::
2016年獲得湖北省優(yōu)秀論文三等獎(jiǎng)；
::公開(kāi)發(fā)表論文及著作：::
[1] Ding Q, He D, He K, Zhang Q, Tang M, Dai J, Lv H, Wang X, Xiang G, Yu H. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumour Biol. 2015 Nov;36(11):8761-72.IF:3.611
[2] Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q, Kang J, He W, Ding Q, He D. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis. Biochem Biophys Res Commun. 2015 Jul 31;463(3):458-65. IF:2.297
[3]He D, Hong L, Guo W. The role low microRNA-335 expression in prognosis prediction of human cancers. Journal of Cancer Research and Therapeutics. 2016 Sep 26;212(3):145-13. IF:1.326
[4] He D, Duan C, Chen J, Lai L, Chen J, Chen D. The safety and efficacy of the preoperative neoadjuvant chemotherapy for patients with cervical cancer: a systematic review and meta analysis. Int J Clin Exp Med. 2015 Sep 15;8(9):14693-700. IF:1.277
[5] Tu Z, He D, Deng X, Xiong M, Huang X, Li X, Hao L, Ding Q, Zhang Q. An eight-long non-coding RNA as a candidate prognostic biomarker for non-small cell lung cancer. Oncol Rep. 2016 Jul;36(1):215-22. IF:3.417
[6] Baowei Ji , Lihua Chen, Qiang Cai, Qiao Guo, Zhibiao Chen and Du He.Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.PeerJ.2020 Sep 28.10.7717. IF:3.5
[7] Du He, Xue Huang, Zai-Ping Wang, Dian Chen, Jun Chen and ChunYan Duan. Dietary fat intake and risk of esophageal carcinoma: a metaanalysis of observational studies.Oncotarget,2017,vol.8,(No.58),pp:99049-99056.7,IF: 5.168.Vol.
[8] Bing Wu, Li Teng, Du He, Dong-Dong Yu & Fan Jiang.Dose-response relation between serum total cholesterol levels and overall cancer risk: evidence
from 12 prospective studies involving 1,926,275 participants.Food Sciences and Nutrition. 2019, VOL. 70, NO. 4, 432–441.IF: 2.1.Vol.
[9]Qin L, Zhao T, Liu X, Wang H, Gu X, Chen D, Wang Z, He D.Malignant transformation arising from mature ovarian cystic teratoma: A case series.Medicine (Baltimore).2021 Apr 2;100(13).